Chronic neutrophilic leukemia historical perspective: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(21 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Chronic neutrophilic leukemia}}
{{Chronic neutrophilic leukemia}}


{{CMG}}; {{AE}}
{{CMG}}; {{AE}} {{Homa}}; {{GRR}} {{Nat}}


==Overview==
==Overview==
Chronic neutrophilic leukemia(CNL) was first presented by Tuohy, in a case of [[splenomegaly]] and neutrophilic [[leukocytosis]], in 1920. Although, It was named by Tanzer et al, in 1964. [[World Health Organization|WHO]] introduced the [[criteria]] for the [[diagnosis]] of this disease as a [[Myeloproliferative neoplasm|myeloproliferative disorder]] in 2001. In 2013, [[CSF3R]] (colony stimulating factor 3 receptor) [[Mutation|mutations]] was proposed that was found in the most CNL patients and made a huge change in [[diagnosis]] and treatment of this patient.
==Historical Perspective==
==Historical Perspective==
===Discovery===
===Discovery===
* Chronic neutrophilic leukemia(CNL) was first presented by Tuohy, in a case of splenomegaly and neutrophilic leukocytosis, in 1920. Although, It was named by Tanzer et al, in 1964.
* In 1920, Tuohy described the first case of CNL with severe [[splenomegaly]] and neutrophilic [[leukocytosis]] as a unique [[disease]]. However, it was named for the fist time as CNL by Tanzer et al, in 1964.<ref name="Tuohy1920">{{cite journal|last1=Tuohy|first1=E. L.|title=A CASE OF SPLENOMEGALY WITH POLYMORPHONUCLEAR NEUTROPHIL HYPERLEUKOCYTOSIS|journal=The American Journal of the Medical Sciences|volume=160|issue=1|year=1920|pages=18–24|issn=0002-9629|doi=10.1097/00000441-192007000-00003}}</ref><ref name="TanzerHarel1964">{{cite journal|last1=Tanzer|first1=J.|last2=Harel|first2=P.|last3=Boiron|first3=M.|last4=Bernard|first4=Jean|title=CYTOCHEMICAL AND CYTOGENETIC FINDINGS IN A CASE OF CHRONIC NEUTROPHILIC LEUKÆMIA OF MATURE CELL TYPE|journal=The Lancet|volume=283|issue=7329|year=1964|pages=387–388|issn=01406736|doi=10.1016/S0140-6736(64)92142-7}}</ref>
* In 2001, WHO introduced the criteria for diagnosis CNL as a myeloproliferative disorder that was revised in 2016.
* In 2001, [[World Health Organization|WHO]] introduced the [[criteria]] for diagnosis CNL as a [[Myeloproliferative neoplasm|myeloproliferative disorder]] that was revised in 2016.<ref name="UppalGong2015">{{cite journal|last1=Uppal|first1=Guldeep|last2=Gong|first2=Jerald|title=Chronic neutrophilic leukaemia|journal=Journal of Clinical Pathology|volume=68|issue=9|year=2015|pages=680–684|issn=0021-9746|doi=10.1136/jclinpath-2015-203060}}</ref>
* In 2013, CSF3R (colony stimulating factor 3 receptor) mutations was proposed that was found in the most CNL patients.
* In 2013, [[CSF3R]] (colony stimulating factor 3 receptor) [[Mutation|mutations]] was proposed that was found in the most CNL [[Patient|patients]].<ref name="MaxsonGotlib2013">{{cite journal|last1=Maxson|first1=Julia E.|last2=Gotlib|first2=Jason|last3=Pollyea|first3=Daniel A.|last4=Fleischman|first4=Angela G.|last5=Agarwal|first5=Anupriya|last6=Eide|first6=Christopher A.|last7=Bottomly|first7=Daniel|last8=Wilmot|first8=Beth|last9=McWeeney|first9=Shannon K.|last10=Tognon|first10=Cristina E.|last11=Pond|first11=J. Blake|last12=Collins|first12=Robert H.|last13=Goueli|first13=Basem|last14=Oh|first14=Stephen T.|last15=Deininger|first15=Michael W.|last16=Chang|first16=Bill H.|last17=Loriaux|first17=Marc M.|last18=Druker|first18=Brian J.|last19=Tyner|first19=Jeffrey W.|title=Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML|journal=New England Journal of Medicine|volume=368|issue=19|year=2013|pages=1781–1790|issn=0028-4793|doi=10.1056/NEJMoa1214514}}</ref>
 
==Landmark Events in the Development of Treatment Strategies==
 
==Impact on Cultural History==
 
==Famous Cases==
The following are a few famous cases of [disease name]:


==References==
==References==
{{Reflist|2}}
{{reflist|2}}


{{WH}}
[[Category:Up-To-Date]]
{{WS}}
[[Category:Medicine]]
[[Category: (name of the system)]]
[[Category:Oncology]]
[[Category:Hematology]]
[[Category:Immunology]]

Latest revision as of 20:57, 29 July 2020

Chronic neutrophilic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Chronic neutrophilic leukemia from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic neutrophilic leukemia historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic neutrophilic leukemia historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic neutrophilic leukemia historical perspective

CDC on Chronic neutrophilic leukemia historical perspective

Chronic neutrophilic leukemia historical perspective in the news

Blogs on Chronic neutrophilic leukemia historical perspective

Directions to Hospitals Treating Chronic neutrophilic leukemia

Risk calculators and risk factors for Chronic neutrophilic leukemia historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]

Overview

Chronic neutrophilic leukemia(CNL) was first presented by Tuohy, in a case of splenomegaly and neutrophilic leukocytosis, in 1920. Although, It was named by Tanzer et al, in 1964. WHO introduced the criteria for the diagnosis of this disease as a myeloproliferative disorder in 2001. In 2013, CSF3R (colony stimulating factor 3 receptor) mutations was proposed that was found in the most CNL patients and made a huge change in diagnosis and treatment of this patient.

Historical Perspective

Discovery

References

  1. Tuohy, E. L. (1920). "A CASE OF SPLENOMEGALY WITH POLYMORPHONUCLEAR NEUTROPHIL HYPERLEUKOCYTOSIS". The American Journal of the Medical Sciences. 160 (1): 18–24. doi:10.1097/00000441-192007000-00003. ISSN 0002-9629.
  2. Tanzer, J.; Harel, P.; Boiron, M.; Bernard, Jean (1964). "CYTOCHEMICAL AND CYTOGENETIC FINDINGS IN A CASE OF CHRONIC NEUTROPHILIC LEUKÆMIA OF MATURE CELL TYPE". The Lancet. 283 (7329): 387–388. doi:10.1016/S0140-6736(64)92142-7. ISSN 0140-6736.
  3. Uppal, Guldeep; Gong, Jerald (2015). "Chronic neutrophilic leukaemia". Journal of Clinical Pathology. 68 (9): 680–684. doi:10.1136/jclinpath-2015-203060. ISSN 0021-9746.
  4. Maxson, Julia E.; Gotlib, Jason; Pollyea, Daniel A.; Fleischman, Angela G.; Agarwal, Anupriya; Eide, Christopher A.; Bottomly, Daniel; Wilmot, Beth; McWeeney, Shannon K.; Tognon, Cristina E.; Pond, J. Blake; Collins, Robert H.; Goueli, Basem; Oh, Stephen T.; Deininger, Michael W.; Chang, Bill H.; Loriaux, Marc M.; Druker, Brian J.; Tyner, Jeffrey W. (2013). "Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML". New England Journal of Medicine. 368 (19): 1781–1790. doi:10.1056/NEJMoa1214514. ISSN 0028-4793.